From October 1, 2023 to January 1, 2024, the company has repurchased 3,014,355 shares, representing 5.93% for $30.43 million. With this, the company has completed the repurchase of 31,414,836 shares, representing 49.07% for $325 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 USD | +1.53% | +3.36% | -23.31% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.31% | 419M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.